taraxerol has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, A; Alkholifi, FK; Aodah, AH; Devi, S; Foudah, AI; Yusufoglu, HS | 1 |
| Jyothi Kumari, P; Lakshmi, BS; Sangeetha, KN; Shilpa, K | 1 |
2 other study(ies) available for taraxerol and Disease Models, Animal
| Article | Year |
|---|---|
Effects of Taraxerol on Oxidative and Inflammatory Mediators in Isoproterenol-Induced Cardiotoxicity in an Animal Model.
Topics: Animals; Antioxidants; Cardiotoxicity; Disease Models, Animal; Inflammation Mediators; Isoproterenol; Myocardial Infarction; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2023 |
Reversal of dexamethasone induced insulin resistance in 3T3L1 adipocytes by 3β-taraxerol of Mangifera indica.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Biomarkers; Dexamethasone; Disease Models, Animal; Drug Evaluation, Preclinical; Glucose; Glucose Transporter Type 4; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Mangifera; Mice; Oleanolic Acid; Phosphatidylinositol 3-Kinases; Phytotherapy; Plant Extracts; Rosiglitazone; Thiazolidinediones | 2013 |